Radiotherapy and Oncology

Article	Citations
Predictive biomarkers of radiotherapy- related dermatitis, xerostomia, mucositis and dysphagia in head and neck cancer: A systematic review	215
Corrigendum to “Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing” [Radiother. Oncol. 200 (2024) 110477]	136
Contents	107
Aims+Scope/Editorial Board/ Publication information	85
Post-operative re-irradiation with hyperthermia in locoregional breast cancer recurrence: Temperature matters	83
HaN-Seg: The head and neck organ-at-risk CT and MR segmentation challenge	80
PD-0242 Comparison of static and dynamic proton arc treatment planning algorithms in oropharyngeal cancer	79
X-ray on chip: Quantifying therapeutic synergies between radiotherapy and anticancer drugs using soft tissue sarcoma tumor spheroids	75
Response to “Comments on ‘Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort st	72
MRI radiomics nomogram integrating postoperative adjuvant treatments in recurrence risk prediction for patients with early-stage cervical cancer	67
Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives	66
Assessment of gaze direction during head and neck irradiation and dosimetric impact on the retina, macula and papilla in a cohort of 240 patients with paraoptic tumors	66
Incidence of hippocampal and perihippocampal brain metastases and impact on hippocampal-avoiding radiotherapy: A systematic review and meta-analysis	65
MRI-based radiomics to compare the survival benefit of induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy in locoregionally advance	65
Factors associated with acute esophagitis during radiation therapy for lung cancer	65
Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis	60
Prediction of the need of enteral nutrition during radiation therapy for head and neck cancers	58
SP-0683 Combining immunotherapy with radiotherapy	58
Training and temporally validating an NTCP model of acute toxicity after whole breast radiotherapy, including the impact of advanced delivery techniques	56
Normal tissue complication probability model for acute oral mucositis in patients with head and neck cancer undergoing carbon ion radiation therapy based on dosimetry, radiomics, and dosiomics	54
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer	54
Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patients	54
Ultra-fast pencil beam scanning proton therapy for locally advanced non-small-cell lung cancers: Field delivery within a single breath-hold	52
Comprehensive summary and retrospective evaluation of prognostic scores for patients with newly diagnosed brain metastases treated with upfront radiosurgery in a modern patient collective	50
Definitive radiotherapy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: A multicenter retrospective study (KROG 21–10)	49

An efficient strategy to select head and neck cancer patients for adaptive radiotherapy	45
Financial toxicity in cancer patients undergoing radiotherapy in a universal health care system – A prospective multicenter study of 1075 patients	44
Long-term outcomes of ultra-hypofractionated 2 fractions single day HDR brachytherapy in localized prostate cancer	44
Stereotactic radioablation of ventricular arrhythmias in patients with structural heart disease – A systematic review	44
Lymph drainage and cervical fascia anatomy-oriented differential nodal CTV delineation at the supraclavicular region for esophageal cancer and nasopharyngeal cancer	44
PO-0244 HDR brachytherapy monotherapy with 2 x 13.5 Gy for localized prostate cancer: short term follow up	44
1353: Impact of VOLOTMUltra optimizer for Radixact system on treatment plan quality and efficiency	43
3235: Predictors of executive function decline after brain RT: a novel NTCP analysis	42
2225: Comparing the Hungarian RTT’s practice in the head and neck region with the ESTRO Guideline	42
1748: Collimated active spot-scanning IMPT vs VMAT for lung SBRT: Dosimetric and robustness comparison	40
1299: Individualised isotoxic radiotherapy for re-irradiation in recurrent pelvic cancers	40
3007: SABR prior to liver transplantation in HCC patients: a 10 years’ experience	38
2121: Should we switch to convolution algorithm when treating AVMs embolized with Onyx?	38
2724: Patient interchangeability between beam-matched accelerators	38
2933: Utility of circulating tumor HPV DNA for oropharynx cancer treated at an urban medical center	37
937: Prediction of the dose-averaged proton linear energy transfer using convolutional neural networks	36
729: Development of an automatic deformable registration workflow for multi-modal prostate imaging	36
2489: Endothelial senescence primes aggressiveness of glioblastoma cells after radiotherapy	36
749: Reinforcement learning for accelerated automatic treatment planning optimization	36
1676: Unexpected correlation between DWI and treatment response in HPV negative oropharyngeal carcinoma	36
987: Pattern-of-Care Analysis for Radiotherapy of Cutaneous Lymphomas Among EORTC Members	36
1998: Automation of Dose Stability Test in Helical Irradiations on Tomotherapy linear accelerators	35
1045: Characterising spatial distribution of imaging parameters in cervical cancer	35
2172: Focused Ultrasound and RadioTHERapy for pain treatment in bone metastasis:an update of FURTHER trial	35
43: CPAP-assisted breathing and Supine Tangent Left Breast RT when DIBH-RT was Ineffective or Unsuitable	35
347: The impact of molecular classification on adjuvant radiotherapy choice for early endometrial cancer	34
438: Less pneumonia after nCRT and resection in oesophageal cancer using proton RT	34
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm	34
893: The impact on overall survival of celiac plexus radiosurgery, post-hoc analysis of a clinical trial	33
480: Simulating radiotherapy induced skin reactions with moulage on all skin types, Phase 1 findings.	33
360: The role of SGRT in detecting inter and intra fraction errors in SBRT treatments to the lung	33
419: surgery versus radiotherapy for limited-stage small cell esophageal carcinoma: a multicenter study	31
1489: Impact of Cardiac Radiation Dose on Subclinical and Clinical Cardiotoxicity HER2+ Breast Cancer	31
2808: Off-line plan evaluation with CBCT-Synthesized-CT in patients treated with DIBH for left breast	31
2959: The Impact of Advanced Algorithms on the Treatment of Meningiomas	30
65: Accuracy of SGRT versus MV EPID-based ball bearing positions for clinical range of couch rotations	30
2211: Investigation of chromosome aberration of different number of CBCT combined with therapeutic beams	30
2180: Outcomes of salvage prostate re-irradiation for local recurrence after definitive radiation therapy	30
330: External validation of rectal cancer CTV auto-contouring with patient-specific prior for online ART	30
3225: Commissioning of the Fricke solution dosimeter for particle therapy	29
2395: Local control and toxicity after upper abdominal SBRT with Simultaneous Integrated Protection (SIP)	29
2177: Impact Metal Implants on Radiotherapy Planning: HU Value Variations with 80kV and 140kV Tube Voltage	29
443: In-situ recalibration of PTW STARCHECK detector array by measuring set of beam profiles	29
2533: Evaluation of set-up uncertainty in Radiosurgery using ExacTrac for validation of PTV margins	28
2124: Respiratory gated planning of non-small cell lung cancer with new data-driven gated (DDG) PET/CT	28
614: National guidelines for QA of deformable dose mapping: Feasibility and effect on dose prescription	28
1254: Tumor Control Probability predictions for Hyperthermia plus Radiotherapy under varying conditions	28
2925: Urethral dosimetric implications of a multifocal MRI-based microboost in prostate robotic SBRT	28
1807: Deep learning-based dose prediction for breast and regional lymph node radiotherapy	28
3138: Mediastinal irradiation for thymic epithelial tumors: A deep focus on coronary arteries’ exposure	28

2208: Implementing photobiomodulation as supportive care activity in an oncology-radiotherapy center	28
452: Can 1 mm PTV margin be used for radiosurgery patients laying on wedges?	28
3310: Challenges and dilemmas in the elderly gynaecological cancer patient	27
3314: Child-friendly on-treatment solutions (RTT perspective)	27
560: Outcomes of stereotactic body radiotherapy on oligometastatic and oligoprogressive breast cancer	27
2311: Treatment plan robustness in IMPT for esophageal cancer: every millimeter counts.	27
1787: MR-guided stereotactic ablative radiotherapy for central lung tumors: long-term clinical outcomes.	26
2562: AI-enhanced proton radiography: deep learning for assessing treatment deviations in proton therapy	26
2997: Comprehensive cosmesis evaluation of ultrahypofractionated adjuvant breast radiotherapy with SIB	26
3006: Clinical markers of altered Body image in Patients with Head and Neck cancers	26
2219: Breaking boundaries: improve flow and create a positive work environment for radiation technologists	26
938: Radiation-induced cerebral contrast enhancements strongly share ischemic stroke risk factors	26
995: Enhancing outcomes: Neoadjuvant chemoradiation in locally advanced operable esophageal cancer.	26
1586: Dose perturbation due to surgical clips and titanium mesh in proton therapy	26
3017: SABR of bony oligometastases, 1-year, efficacy, and toxicity analyses from the Bony-M trial	26
24: Experience on patient- specific QA for HyperArc stereotatic plans	26
2310: The development of a UK curriculum for therapeutic radiographers at an advanced level of practice.	26
154: Identifying the Continuous Professional Development Educational Needs of Belgian RTTs	26
1348: Clinical application of a probabilistic robustness evaluation tool for proton therapy treatments	25
2848: Stereotactic body radiotherapy in elderly pancreatic cancer patients: single-institution experience	25
1127: Analysis of interstitial catheter number and dosimetric parameters in cervical cancer brachytherapy	24
3185: Retrospective analysis of output data for ten linear accelerators at Northern Ireland Cancer Centre	24
3194: LA-NSCLC: clinical outcomes and comparison of 2-weekly versus 4-weekly durvalumab consolidation	24
2999: Craniospinal irradiation in Helical Tomotherapy: Dosimetric analysis and acute toxicity evaluation	24
649: HDR brachytherapy as monotherapy in the treatment of prostate cancer	24
2437: Clinical predictors of late lymphopenia in PCa patients undergoing radical or post-operative WPRT	24
1432: Comparative study of various homogeneity indices in SIB-VMAT planning for head and neck tumors.	24
2119: Comparative Evaluation of 4DCT and 3D T1/T2w MRI in Delineation of Moving Target: A Phantom Study	24
2128: Individual organ dose calculations from CT imaging of Hodgkin lymphoma patients treated with protons	24
773: FGFR2+ fibroblast-derived BMP5 promoted radioresistance in esophageal carcinoma	24
940: Implementing plan of the day for cervix cancer: which contouring method and margins to use	24
1974: Acute Toxicity in a Randomized Trial of MRI-guided Salvage RT for Prostate Cancer in 4 vs. 2 Weeks	24
1463: NG11-2 Phase Ib trial to reduce radiation-induced oral mucositis on patients with head & neck cancer	24
70: Developing imaging biomarkers for the incidence of RP in patients with NSCLC who have underlying IPF	24
2422: Comparison of the patient movement in thorax treatments with free breathing and DIBH with SGRT	23
134: The predictive value of Equivalent Uniform Dose (EUD) in Microbeam Radiation Therapy (MRT)	23
479: Field output correction factors of small static field for IBA Razor NanoChamber	23
994: Terminology, Recording, Reporting for Ultra-High Dose Rates: ESTRO Physics of FLASH Workshop update	23
655: FET-PET and MRI integration in the planning process of HGG treated with adjuvant radiochemotherapy	23
2238: Efficacy and Safety of Low Dose Radiation Therapy for Alzheimer’s Disease: Phase II Clinical Trial	23
1193: Cytokines modulation by pelvic RT with simultaneous hypofractionated boost in prostate cancer	23
680: SAPPHIRE - Establishment of Small Animal Proton and PHoton IRradiation Experiments	23
2681: Management of air in rectum and anal canal during adaptive radiotherapy.	23
3119: Large bicentric study on dosimetric changes during head and neck radiotherapy	23
285: Metal artifact in MR-based synthetic CT for intracranial radiotherapy: impact on dosimetry and setup	23
780: Proton radiotherapy in meningioma and hemangiopericytoma: a monocentric clinical report	23
444: Sensitivity and specificity evaluation of PerFRACTION in a HALCYON 2.0	23
735: Patterns of care and outcome of liver SBRT: results from a multicentre national quality project.	23
3123: Stereotactic body radiotherapy for extracranial, intracranial or mixed-pattern oligometastatic NSCLC	23
80: Overview of tumour sterilization rates in rectal cancers among treatment modalities; is more better?	22
1329: Development of a Mobile Application to Support Prostate Cancer Patients Undergoing Radiotherapy	22
3078: Enhancing Treatment Quality and Patient Safety: Streamlined Process Using 3D In-Vivo Dosimetry	22
1856: Radiation therapists implication in research and transversal projects - Experience of Caen Center	22
2035: Salvage stereotactic radiosurgery after whole brain radiotherapy in non-small cell lung cancer	22
2060: Stereotactic Body Radiation Therapy (SBRT) for pain control in spinal metastases	22
1086: Urethra-sparing single-dose ablative prostate radiotherapy with real-time motion management	22
1062: Micro-dissected tumour tissues-on-chip; a tool for translational radiation oncology	21
1043: External validation of automated treatment planning for HDR prostate brachytherapy using BRIGHT	21
2522: Optimal pressure of CPAP for reduction mean heart dose in left-sided breast cancer radiotherapy	21
768: Proton minibeam radiation therapy is a promising approach for re-irradiations	21
1695: Time-resolved analysis of clinical dose metrics for HDR brachytherapy error detection	21
2581: PET/MR imaging biomarkers of radioresistance in anal cancer patients	21
1715: Pathological Phenotypes and Radiation Sensitivity of Airway Stem Cells Derived from COPD Patients.	21
3231: Creating similarly robust plans for different radiotherapy delivery systems	21
2529: ‘Tribrid’ teaching: The optimal model for 21st century clinical oncology education?	21
2175: SBRT vs SBRT + HDR-boost: a prospective comparative analysis of toxicity, QoL and disease control.	20
1599: Optimization of the comparison metric for EPID in vivo dosimetry of lung treatment	20
2769: TRIBBLES1 (TRIB1) pseudokinase- mediated modulation of p53 function through COP1 and/or HDAC1 in GBM	20
385: Teaching and AI-Assistance Improve Organs-At-Risk Contouring for Head-Neck Cancer in a Global Study	20
1876: On table adaptation in MR Guided prostate cancer treatments. Can RTTs replace the physician?	20
1568: Toward multi-institutional Knowledge-Based benchmark for right and left whole breast irradiation	20
1142: Treatment-related parameters and acute toxicity in salvage radiotherapy of prostate cancer	20
1635: In vivo dosimetry - keeping my finger on the pulse	19
2605: HDR brachytherapy boost plus EBRT in unfavorable prostate cancer: results in more then 700 patients	19
3046: Factors influencing adaptive radiotherapy and tumor dynamics in cervical cancer treatment	19
771: Hypofractionated dose-escalated salvage RT for macroscopic prostate cancer local recurrence	19
2543: Characterization of the oxygen transport variation with dose on a cohort of breast cancer patients	19
3318: Collaborative research initiatives: Unleashing the potential of RTTs worldwide	19
1749: Dosimetry and survival in unresectable primary HCC patients undergoing resin 90Y SIRT	19
284: Time-dependent diffusion MRI for tumor characterization in biologically adapted radiotherapy	19

2803: Treatment outcomes of intra-arterial chemoradiotherapy for oral cavity squamous cell carcinoma.	19
3040: Radiotherapy-related quality of life in patients with Gynecological cancer	19
2601: Guidelines-based automatic segmentation improvements	19
90: Delta CT radiomics features predicts prognosis after neoadjuvant chemotherapy in gastric-cancer	18
3490: Risk-adapted and response-adapted strategies for stage 3 NSCLC	18
3093: Derivation of radiomic classifiers for radiotherapy response in locally advanced rectal cancer	18
3622: Single-cell analysis of lung responses to radiation injury	18
1271: Improving breast cancer radiotherapy: determine need for plan adaptation based on corrected CBCTs	18
394: Dosimetric evaluation of synthetic 3DCTs reconstructed from a single x-ray radiograph using CNN	18
3162: Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer	18
1247: ANTI-TUMOR AND ACUTE TOXICITY OF FRACTIONATED STEREOTACTIC RADIOTHERAPY COMBINED WITH HYPERTHERMIA	18
3315: Greening our hospitals: circular economy in healthcare & green skills for RTT – What we know?	18
722: Standard versus highly hypofractionated tumor irradiation in LA-NSCLC with durvalumab consolidation	18
3149: The toxicity and value of interstitial brachytherapy boost for high-risk breast cancer patients	18
503: A study comparing response for weekly v/s three weekly cisplatin in accelerated CRT for HNSCC	18
1028: Is volumetric repainting needed to minimize interplay induced dose effects in lung proton therapy?	18
3470: Quality of life and cosmetic assessment in skin cancer treatment	18
2559: Outcomes of intracranial germ cell tumours treated at a single UK proton centre	18
511: Enhanced IMPT dose fall-off by optimised integration of Bragg peaks and transmission pencil beams	18
3335: Fairness in radiotherapy data use analysis & outcome modelling	18
2486: Impact of patient specific deep learning OAR segmentation on accumulated online adapted MRgRT dose	18
2019: The Impact of Concurrent Chemotherapy on Stage II Nasopharyngeal Carcinoma	18
2797: Initial Clinical and Dosimetric outcomes with TBI planned on Helical Tomotherapy	18
2053: An Italian multi-department study for relative dosimetry in tomotherapy	18
1442: EBUS-guided fiducial placement for SBRT in mediastinal nodal oligometastases	18
890: Impact of cumulative cisplatin-dose on distant metastasis after chemoradiation of cervical cancer	18
262: Radiation induces Mitochondrial Biogenesis and Cellular Quiescence Exit in PDOX models of pHGG	18
3128: Self-applied photobiomodulation therapy for radiation toxicity in head and neck cancer patients	18
1096: Classical prognostic factors outperform SUV-max in LACC: an observational study	18
1059: Predictive value of tumor volume change during chemoradiotherapy in non-small cell lung cancer	18
916: Dosimetric characterization of the FLASHKNiFE 10 MeV UHDR beam towards clinical translation	17
2932: Oligometastatic liver SABR: clinical outcomes and evaluation of relapse pattern	17
3277: A cyber-attack response plan: How to ensure that patients continue to be treated (correctly)	17
941: Should Varian HyperArc make us re-think how we use conventional linacs for SRS?	17
1689: Double Shell Positioning System versus Thermoplastic Shell For Brain Radiotherapy	17
158: Validation of intrafraction prostate drift corrections on a 1.5T MR-linac using cine-MRI	17
1952: Leveraging hybrid PET/MR imaging to distinguish progression from radionecrosis post-radiosurgery	17
972: Proton therapy for patients with meningioma—Long-term outcomes from ProReg and KiProReg study	17
1850: Factors predict Complete Histological Response following neoadjuvant radiotherapy for rectal cancer	17
1060: Validation of a parameterised automated VMAT technique for SIB radiotherapy of head and neck cancer.	17
2428: Radiotherapy or cystectomy in muscle-invasive bladder cancer: Outcomes with two clinical pathways	17
1785: Comparison between Ethos measurements and dosimetric parametres calculated with Acuros XB Beam Model	17
1622: Title: Gamma Knife Radiosurgery for Trigeminal Neuralgia: A review of 59 patients	17
1979: Predicting radionecrosis following different radiotherapy dose for intracranial meningiomas	17
159: Measurement of output factor for Cyberknife using scintillation dosimetry and deep learning	17
1639: Robust VMAT dose planning on breast patients and selection of optimization bolus.	17
2679: ROLE OF STEREOTACTIC RADIOTHERAPY IN OLIGO-RECURRENCE OF PLEURAL MESOTHELIOMA	17
139: Stereotactic radiosurgery in elderly patients with brain metastases from non-small cell lung cancer	17
1603: Early cardiac functional and gene expression markers after irradiation of cardiac substructures	17
1377: Dose Prediction for Prostate Radiotherapy Planning	16
1305: Impact of Abdominal Compression in SBRT for upper abdominal tumors	16
335: 0 mm PTV margin to reduce toxicity in MRI-guided RT for favorable intermediate-risk prostate cancer	16
2025: Dosiomics models for prediction of skin toxicity after radiotherapy in breast cancer patients	16
2476: Enhancing Patient Education: Assessing radiation therapists' understanding of hospital guidance.	16
552: First-in-human breast imaging study with ultra-low field MRI for compact proton therapy systems	16
691: A single-arm confirmatory trial of IMRT alone for early-stage oropharyngeal cancer: JCOG1208	16
2749: Feasibility of SBRT with CK in the scenario of lung metastases re-RT: monoinstitutional experience.	16
2434: The radiobiological principles of low dose radiotherapy for non-cancer diseases	16
1215: Oligometastatic Mesothelioma treated with Ablative Radiotherapy (OMAR): multi-institutional database	16
1243: Evaluation of organ at risk contours in breast cancer patients: the role of radiation therapist	16
2278: Decision aids and treatment regret in patients with localised prostate cancer: a systematic review	16
529: Use of a radar plot to assess cervical HDR brachytherapy plans and correlate with clinical outcomes	16
2752: A phantom study of robust analysis of Lung SBRT BH plan	15
1728: Development of a Preclinical X-ray Minibeam Monte Carlo Treatment Planning System using Topas	15
895: Predicting Overall Survival for Patients Who Underwent Adjuvant Chemoradiotherapy for Gastric Cancer	15
1014: Dosimetric evaluation of accelerated partial breast irradiation using VMAT technique	15
441: SGRT-based stereotactic body radiotherapy for lung cancer setup accuracy and PTV margins	15
2070: The benefits of pneumatic compression belt in liver tumor radiotherapy	15
2981: Inflammatory indexes prognostic value in STS patients treated with preoperative chemoradiation	15
1861: Performance of a heart substructures autocontouring tool after clinical implementation	15
1517: Intramedullary and leptomeningeal-epidural metastases. Outcomes of a rare and ominous condition.	15
3336: Finding the right tool for patients and health care professionals	15
3312: Challenges in radiopharmaceutical development and evaluation	15
362: Advanced-fractured osteoradionecrosis in long-survivor ENT cancer patients: a medical challenge?	15
1573: Automated audit of planned versus delivered radiotherapy	15
3061: Gut microbiome and gene expression changes during a Phase 1 trial of enadenotucirev and radiotherapy	15
95: Phase Ib trial of Durvalumab plus tremelimumab with particle therapy for advanced HCC: DEPARTURE	15
3502: Standardising complex treatments like Total Body Irradiation (TBI) and Total Marrow and Lymph node Irradiation (TMLI)	15
1763: A compact gamma-ray detector coupled with a pinhole collimator for real-time dose monitoring in BNCT	15
2334: Can real-world data be used to assess toxicity of lung radiotherapy? A data quality audit.	15
2078: Clinical outcome of palliative radiotherapy for oligometastatic and non-oligometastatic lung cancer.	15
3429: Modulating innate immunity by DNA damage response inhibition	14
1647: Proton beam therapy image-guided radiotherapy training for RTTs: Experience from a single centre	14
2008: A Generative Adversarial Network for Radiotherapy Dose Predictions of Head and Neck Cancers	14
1583: Phantom-based optimization of virtual monoenergetic image reconstruction in dual-energy CT	14
2811: Two brachytherapy techniques for the management of lower third vaginal involvement in cervix cancer	14
901: Guidelines for dosimetric tracking using reference points in radiation oncology information systems	14
1878: Early experience with GTV boost for prostate cancer: a comparison of MR-Linac and HDR brachytherapy	14
3023: ENRT vs MDT for prostate cancer lymph nodal relapses: a preliminary analysis	14
2975: UHRT in PCa: a clinical and toxicity impact analysis from real world experience.	14
1664: Assessing overall and fractional CTV coverage in breast cancer radiotherapy based on daily imaging	14
1514: Combining TiO2 loaded gel with radiotherapy to enhance anticancer effect for glioblastoma	14
336: Radiation-induced lymphopenia predicts poor survival in HCC patients treated with radiotherapy	14
1609: A review assessing the impact of COVID-19 on radiotherapy activity in Scotland, 2 years post-COVID	14
3113: Determination of the correction factor kQ of PTW Semiflex3D for reference dosimetry at ZAP-X system	14